- Home
- GNTY vs IMTX Comparison
GNTY vs IMTX Comparison
Compare GNTY & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNTY
- IMTX
- Stock Information
- Founded
- GNTY 1913
- IMTX N/A
- Country
- GNTY United States
- IMTX Germany
- Employees
- GNTY N/A
- IMTX N/A
- Industry
- GNTY Major Banks
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GNTY Finance
- IMTX Health Care
- Exchange
- GNTY Nasdaq
- IMTX Nasdaq
- Market Cap
- GNTY 434.5M
- IMTX 514.2M
- IPO Year
- GNTY 2017
- IMTX N/A
- Fundamental
- Price
- GNTY $40.65
- IMTX $4.49
- Analyst Decision
- GNTY Buy
- IMTX Strong Buy
- Analyst Count
- GNTY 2
- IMTX 4
- Target Price
- GNTY $41.00
- IMTX $16.67
- AVG Volume (30 Days)
- GNTY 32.8K
- IMTX 837.3K
- Earning Date
- GNTY 04-21-2025
- IMTX 05-13-2025
- Dividend Yield
- GNTY 2.50%
- IMTX N/A
- EPS Growth
- GNTY 18.89
- IMTX N/A
- EPS
- GNTY 2.91
- IMTX 0.14
- Revenue
- GNTY $123,780,000.00
- IMTX $161,336,577.00
- Revenue This Year
- GNTY $8.59
- IMTX N/A
- Revenue Next Year
- GNTY $4.53
- IMTX $18.80
- P/E Ratio
- GNTY $13.74
- IMTX $29.87
- Revenue Growth
- GNTY 4.44
- IMTX 188.60
- 52 Week Low
- GNTY $27.01
- IMTX $3.30
- 52 Week High
- GNTY $42.95
- IMTX $13.77
- Technical
- Relative Strength Index (RSI)
- GNTY 63.91
- IMTX 53.17
- Support Level
- GNTY $38.25
- IMTX $4.16
- Resistance Level
- GNTY $39.79
- IMTX $4.39
- Average True Range (ATR)
- GNTY 1.75
- IMTX 0.35
- MACD
- GNTY 0.33
- IMTX 0.07
- Stochastic Oscillator
- GNTY 100.00
- IMTX 85.51
About GNTY Guaranty Bancshares Inc.
Guaranty Bancshares Inc is a bank holding company conducting banking activities through its wholly-owned subsidiary. The company provides its customers with a full array of relationship-driven commercial and consumer banking products and services, as well as mortgage, trust, and wealth management products and services that are tailored to meet the needs of small and medium-sized businesses, professionals, and individuals. It also provides other services such as Credit cards, Personal Loans, Business Checking, Treasury Management, and other related services. The company generates its revenue from interest on loans and investments, customer service and loan fees, fees related to the sale of mortgage loans, and trust and wealth management services.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.